EMCYT CAP 140MG DIN 01990934
Status: Cancelled Post Market
Holder: KABI PHARMACIA CANADA INC.
Molecule: ESTRAMUSTINE PHOSPHATE SODIUM
Health Canada record
| Active ingredient(s) | ESTRAMUSTINE PHOSPHATE SODIUM 140 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01XX11 ESTRAMUSTINE |
| Original market date | 31-Dec-1993 |
| Current status date | 10-Sep-1996 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ESTRAMUSTINE PHOSPHATE SODIUM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02063794 | EMCYT | PFIZER CANADA ULC | Capsule | ESTRAMUSTINE PHOSPHATE SODIUM 140 MG | Cancelled Post Market |
International API supply for ESTRAMUSTINE PHOSPHATE SODIUM
0 valid EDQM Certificates of Suitability from 0 holders. 0 active FDA Drug Master Files.
Request a quote for EMCYT CAP 140MG